StreetInsider.com News Articles

KeyBanc on BrightSpring Health (BTSG): 'Valuation More Attractive Following Pullback'

Mon, 03 Aug 2026 09:54:19 -0400

KeyBanc analyst Matthew Gillmor reiterated an Overweight rating and $80.00 price target on BrightSpring Health (NASDAQ: BTSG).

The analyst commented: "Strong Quarter, Valuation More Attractive Following Pullback; 2Q results were strong. EBITDA grew 44% y/y and beat cons by 6%, driven by continued momentum with Specialty Pharmacy and upside with Provider Services. However, the stock declined 18% (vs. SPX +1%), which we think was driven by elevated expectations, PE overhang, and confusion on GP/script. In our view, fundamentals remain strong, supported by: 1) strength of BTSG's Onco360 SP to capture LDDs and generic conversions; 2) capital deployment optionality; and 3) reasonably

BrightSpring Health (BTSG) PT Lowered to $75 at Raymond James

Mon, 03 Aug 2026 06:04:27 -0400

Raymond James analyst Parker Snure lowered the price target on BrightSpring Health (NASDAQ: BTSG) to $75.00 (from $80.00) while maintaining a Outperform rating.

BrightSpring Health Services, Inc. (BTSG) Tops Q2 EPS by 24c ; Offers Guidnce

Fri, 31 Jul 2026 06:20:17 -0400

BrightSpring Health Services, Inc. (NASDAQ: BTSG) reported Q2 EPS of $0.42, $0.24 better than the analyst estimate of $0.18. Revenue for the quarter came in at $3.87 billion.

GUIDANCE:

BrightSpring Health Services, Inc. sees FY2026 revenue of $15.1-15.42 billion, versus the consensus of $15.07 billion.

For earnings history and earnings-related data on BrightSpring Health Services, Inc. (BTSG) click here.

BrightSpring Health Services, Inc. (BTSG) Tops Q2 EPS by 24c ; Offers Guidnce

Fri, 31 Jul 2026 06:20:17 -0400

BrightSpring Health Services, Inc. (NASDAQ: BTSG) reported Q2 EPS of $0.42, $0.24 better than the analyst estimate of $0.18. Revenue for the quarter came in at $3.87 billion.

GUIDANCE:

BrightSpring Health Services, Inc. sees FY2026 revenue of $15.1-15.42 billion, versus the consensus of $15.07 billion.

For earnings history and earnings-related data on BrightSpring Health Services, Inc. (BTSG) click here.

BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance

Fri, 31 Jul 2026 06:00:00 -0400

LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the second quarter ended June 30, 2026, and increased full year 2026 Revenue and Adjusted EBITDA¹ guidance.

Second Quarter 2026 Financial Highlights
(note: On March 30, 2026, BrightSpring completed the divestiture of the Community Living business and as such, all financial results provided pertain to continuing operations)

Net revenue of $3,873 million, up 23.0% compared to $3,148 million

BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance

Fri, 31 Jul 2026 06:00:00 -0400

Net revenue of $3,873 million, up 23.0% compared to $3,148 million

Form 4 BrightSpring Health Serv For: Jul 25 Filed by: ROUSSEAU JON B

Tue, 28 Jul 2026 20:31:00 -0400

si-local-file:///var/storage/secattach/20260728/26828705.html

Form 4 BrightSpring Health Serv For: Jul 25 Filed by: ROUSSEAU JON B

Tue, 28 Jul 2026 20:31:00 -0400

si-local-file:///var/storage/secattach/20260728/26828705.html

Form 4 BrightSpring Health Serv For: Jul 25 Filed by: ROUSSEAU JON B

Tue, 28 Jul 2026 20:31:00 -0400

si-local-file:///var/storage/secattach/20260728/26828705.html

BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600